ID   RVH-421 Dab-R
AC   CVCL_A1VM
SY   RVH421_Dab; RVH421 SKIN FV1; RVH421SKINFV1
DR   cancercelllines; CVCL_A1VM
DR   DepMap; ACH-002461
DR   Wikidata; Q105510831
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (DepMap=ACH-002461).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln52fs*71 (c.154delC); Zygosity=Heterozygous (DepMap=ACH-002461).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1672 ! RVH-421
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 8
//